Predicting cachexia in hepatocellular carcinoma patients: a nomogram based on MRI features and body composition

Approximately half of all patients with hepatocellular carcinoma (HCC) develop cachexia during the course of the disease. It is important to be able to predict which patients will develop cachexia at an early stage.